Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Endoscopic sleeve gastroplasty with fundal mucosal ablation for weight loss

Official title: Endoscopic Sleeve Gastroplasty With Fundal Mucosal Ablation - a Pilot Study

Run by Chinese University of Hong Kong · NCT06790329 · Data updated 2026-11-12

This study is testing a new weight loss method that combines a procedure called endoscopic sleeve gastroplasty with a technique to reduce a hormone that makes you feel hungry, to see if it helps people lose more weight safely.

More Obesity and Obesity-related Medical Conditions trials

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment10 (estimated)
SponsorChinese University of Hong Kong
Academic / other
Locations1 site (Shatin)
StatusRecruiting
StartedJanuary 1, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2027
Registry record updatedJanuary 24, 2025
Trial IDNCT06790329 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with a BMI of 30-40 kg/m2 who have failed standard obesity treatments and are either high-risk for surgery or unwilling to undergo surgical options.

Probably not a fit

Patients with previous upper gastrointestinal surgeries or those with certain medical conditions such as severe coagulopathy or uncontrolled endocrine disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study evaluates the effectiveness and safety of combining endoscopic sleeve gastroplasty (ESG) with a new technique of fundal mucosal ablation to enhance weight loss outcomes. ESG is a minimally invasive procedure that mimics the effects of gastric sleeve surgery but traditionally does not affect the gastric fundus, which is linked to ghrelin production. By incorporating fundal ablation, the study aims to reduce fasting plasma ghrelin levels and improve weight loss results. Participants will be monitored for both physiological effects and overall safety during the intervention.

Why it matters

Potential benefit: If successful, this approach could lead to more effective weight loss solutions for patients struggling with obesity.

How similar studies have gone: While ESG has shown promise, the combination with fundal mucosal ablation is a novel approach that has not been extensively tested in previous studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* BMI equal or more than 30kg/m2 (27.5kg/m2 for Chinese or South Asian) to 40kg/m2, or BMI equal or more than 40kg/m2 and patient is either high risk for surgery or unwilling to undergo surgery, AND
* failed standard obesity therapy of diet, exercise, behavior modification, and pharmacologic agents either alone or in combination

Exclusion Criteria:

* Previous upper GI surgery (e.g. bariatric surgery, anti-reflux surgery; gastrectomy; esophageal surgery)
* Previous ESG
* Gastroparesis
* Active smoking
* An ongoing or a history of treatment with opioids in the last 12 months prior to enrollment
* Previous pyloromyotomy or pyloroplasty
* Gastrointestinal obstruction
* Use of any medication that may interfere with weight loss or gastric emptying
* Severe coagulopathy
* Esophageal or gastric varices and/or portal hypertensive gastropathy
* Underlying uncontrolled endocrine problem that leads to obesity. (e.g. Hypothyroidism, Cushing syndrome, eating disorder etc.)
* Any inflammatory disease of the gastrointestinal tract (including but not limited to severe (LA Grade C or D) esophagitis, active gastric ulceration, active duodenal ulceration, or specific inflammation such as Crohn's disease)
* Malignancy
* Pregnant or breast feeding
* Patients not fit for general anesthesia
* ASA grade IV or V
* Mental or psychiatric disorder; Drug or alcohol addiction
* Other cases deemed by the examining physician as unsuitable for safe treatment
* Refusal to participate

Where it's running

  • Chinese University of Hong Kong
    Shatin, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.